Ackermans & Van Haaren – link to home page Ackermans & Van Haaren – link to home page
Banner image

VICO Therapeutics

Vico Therapeutics

Vico Therapeutics is a Dutch biotech company developing novel Antisense-Oligonucleotide (ASO) therapies for rare diseases.

Included in the AvH investment portfolio since 2024.

Visit website Back > Life sciences portfolio

10.30 %

Beneficial interest AvH

Press releases

View All
Growth Capital

Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors

Read more
Growth Capital

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554

Read more

Related participations

About Dicover ,more

Growth Capital

Agidens

provides advice, automation and maintenance services for five focus markets: Life Sciences, Tank Terminals, Food & Beverage, Infrastructure and Chemistry.

Read more
About Dicover ,more

Growth Capital

Van Moer Logistics

A leading logistics player in the port of Antwerp, totally committed to multimodal transport: inland shipping combined with rail and road transport.

Read more
About Dicover ,more

Growth Capital

Venturi Partners

Singapore-based fund manager with a singular focus on the consumer space in India & South-East Asia.

Read more